Wontech Holds 'Wave Tokyo' in Tokyo, Japan, Officially Launching Sandro Dual

Medical laser company Wontech officially launched its newly approved 'Sandro Dual' device in Japan at the 'Wave Tokyo' event, aiming to expand its brand in major Asian markets. The device features a 'Hybrid Mode' and has acquired regulatory approval in the US, Taiwan, and Japan.
新製品NQ 0/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: April 22, 2026 at 23:46
  • 🔍 Collected: April 23, 2026 at 00:02 (15 min after Published)
  • 🤖 AI Analyzed: April 23, 2026 at 03:48 (3h 46m after Collected)
* Official launch of 'Sandro Dual', introducing product competitiveness such as clinical results
* Meeting with Japanese medical professionals and key customers/partners to convey the product's clinical value and technological distinctiveness
* This year, as the inaugural year of Wave, brand expansion is set to go into full swing targeting major global markets

▲ Scene from 'Wave Beijing' held in Beijing, China on Tuesday, 4/21

(2026-04-23) Wontech Co., Ltd. (Co-CEOs Jong-Won Kim and Jeong-Hyun Kim), a medical solutions company based on laser and energy technology, holds 'Wave Tokyo' in Tokyo to officially launch the 'Sandro Dual'.

'Wave Tokyo' will be held on Sunday, the 26th, at the Four Seasons Hotel Otemachi in Tokyo, Japan. Following the successful completion of 'Wave Beijing' in China on Tuesday, the 21st, holding it consecutively in Japan shows that Wontech's penetration into the Asian market is in full swing.

The core of this event is the official launch of the 'Sandro Dual', which recently obtained regulatory approval in the Japanese market. Following FDA certification in the US, the Sandro Dual is a combined laser device that successfully obtained TFDA approval in Taiwan in January this year and manufacturing and marketing approval under Japan's Pharmaceuticals and Medical Devices Act at the end of March. By consecutively acquiring certifications in major regulated markets recently, it is demonstrating its global product competitiveness.

The Sandro Dual, which has acquired manufacturing and marketing approval in Japan this time, is applicable to dermatological treatments related to long-term hair reduction. Its feature is the 'Hybrid Mode', which continuously irradiates two wavelengths of 755nm and 1064nm with a short time difference, allowing a combination of different wavelength characteristics to be applied to the target area.

Wontech's strategy is to present a broad product portfolio and technological reliability to Japanese medical professionals and partners by simultaneously offering the introduction of new devices and the clinical superiority of its existing major lineups.

An official from Wontech stated, 'Japan is an important market where not only product quality but also clinical reliability and local relationships determine market success. Therefore, we want to make Wave Tokyo not just a launch event, but a starting point for substantial business expansion.' They emphasized, 'Taking advantage of the competitiveness of our portfolio, including the Sandro Dual, we will preempt major Asian markets while at the same time initiating full-scale brand expansion targeting major global markets, positioning this year as the first year of Wave.'

Meanwhile, Wontech is continuing 'Wave (Wontech Advanced Visionary Exchange)', a global brand event to directly share its accumulated technological capabilities, clinical experience, and global vision with medical professionals and partners. Starting in South Korea in March, it has been held consecutively in four countries including the US, China, and Japan, simultaneously promoting localized strategies for each country and the expansion of its global business.

WONTECH JAPAN Co., Ltd.

WONTECH JAPAN Co., Ltd. is the Japanese subsidiary of Wontech Co., Ltd., a medical device manufacturer originating from South Korea, providing advanced laser devices primarily in the field of aesthetic medicine. The parent company places great emphasis on research and development, and is advancing its global expansion backed by its technological prowess. In Japan, in addition to providing products to medical institutions, the company also focuses on building trust with the medical frontline through academic conferences and seminars.

Company Name: WONTECH JAPAN Co., Ltd.
Representative Director: Yasuhito Tanaka
Location: East Yaesu Place, 3-16-6 Hatchobori, Chuo-ku, Tokyo 103-0032
Website: https://wontech-japan.com/